Global Aquaculture Therapeutics Market Research Report 2023

Publisher Name :
Date: 06-Feb-2023
No. of pages: 104
Inquire Before Buying

The Farming or the culturing of aquatic animals like the fishes, algae, mollusks, crustaceans, aquatic plants and other aquatic organisms in different types of water is termed as Aquaculture. The cultivation process involves nurturing of these aquatic organism in the controlled condition either in fresh or in salt water. Later on these aquatic organisms are then harvested to be served as the source of nutrition or to be used for many other purposes. The aquatic animals are very sensitive and are prone to various epidemic diseases. Other factors affecting the aquatic cultured animals are Pathogens (e.g. bacteria, viruses, fungi and parasites) exist in all natural water bodies. At the same time crowded culture environment makes the causes high risk for infection and makes the fishes nervous. Crowding also results in fish knocking eventually leading to surface wounds which is a cause for inaction. These can be cured using several FDA approved antibiotics and other medicines. Apart from diseases medicines are used to improve the wellbeing of the fishes in the aquaculture. The list of drugs includes chorionic gonadotropin, formalin solution, florfenicol, oxytetracycline, tricaine methane sulfonate, hydrogen peroxide, sulfadimethoxine/ormetoprim combination, acetic acid, calcium chloride, calcium oxide, carbon dioxide gas, fuller's earth, garlic (whole form), ice, magnesium sulfate, papain, potassium chloride, povidone iodine, sodium bicarbonate, sodium chloride, sodium sulfite, thiamine hydrochloride, urea and tannic acid. The above mentioned drugs take care of the aquatic animals fighting with several diseases which are not only harmful to the aquatic animals but are also harmful to the consumer. There are two different categories of diseases which affect the aquatic population viz. diseases due to pathogens which are indigenous to the local environment and exotic pathogens.

The global Aquaculture Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

A lot of advancements are taking place in the aquaculture therapeutics as there are several diseases affecting the animals cultured in the aquaculture. There are several diseases driving the aquaculture therapeutics market. Mostly these diseases are dependent on hygiene conditions that are to be maintained. Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs are the factors expected to drive the growth of aquaculture therapeutics market. Also, the demand for aquaculture is rapidly growing day by day due to the decreasing number of the oceanic fish and increasing consumption of the fishes at a global level.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aquaculture Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aquaculture Therapeutics.

The Aquaculture Therapeutics market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Aquaculture Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aquaculture Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- TunaTech GmbH

- ViAqua Therapeutics Ltd.

- Alpharma Inc.

- Blue Ridge Aquaculture

- Cermaq ASA

- Cooke Aquaculture

- Nireus Aquaculture S.A.

- Tassal group Ltd.

- Nireus S.A.

- Unima Group

- Nutreco Holding N.V.

- Kona Bay Marine Resources

- Royal Greenland

- Sea Watch International Ltd.

- Selonda Aquaculture S.A.

- StarKist Taylor Shellfish Inc.

- TriMarine International

- Seafood Company

Segment by Type

- Formalin Solution

- Chorionic Gonadotropin

- Florfenicol

- Tricaine Methane Sulfonate

- Oxytetracycline

- Hydrogen Peroxide

Segment by Application

- Veterinary Pharmacies

- Veterinary Hospitals

- E-Commerce

- Veterinary Clinics

Production by Region

- North America

- Europe

- China

- Japan

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - China Taiwan

- - Southeast Asia

- - India

- Latin America

- - Mexico

- - Brazil

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Aquaculture Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Aquaculture Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Aquaculture Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Global Aquaculture Therapeutics Market Research Report 2023

Table of Contents
1 Aquaculture Therapeutics Market Overview
1.1 Product Definition
1.2 Aquaculture Therapeutics Segment by Type
1.2.1 Global Aquaculture Therapeutics Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Formalin Solution
1.2.3 Chorionic Gonadotropin
1.2.4 Florfenicol
1.2.5 Tricaine Methane Sulfonate
1.2.6 Oxytetracycline
1.2.7 Hydrogen Peroxide
1.3 Aquaculture Therapeutics Segment by Application
1.3.1 Global Aquaculture Therapeutics Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Veterinary Pharmacies
1.3.3 Veterinary Hospitals
1.3.4 E-Commerce
1.3.5 Veterinary Clinics
1.4 Global Market Growth Prospects
1.4.1 Global Aquaculture Therapeutics Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Aquaculture Therapeutics Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Aquaculture Therapeutics Production Estimates and Forecasts (2018-2029)
1.4.4 Global Aquaculture Therapeutics Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Aquaculture Therapeutics Production Market Share by Manufacturers (2018-2023)
2.2 Global Aquaculture Therapeutics Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Aquaculture Therapeutics, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Aquaculture Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Aquaculture Therapeutics Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Aquaculture Therapeutics, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Aquaculture Therapeutics, Product Offered and Application
2.8 Global Key Manufacturers of Aquaculture Therapeutics, Date of Enter into This Industry
2.9 Aquaculture Therapeutics Market Competitive Situation and Trends
2.9.1 Aquaculture Therapeutics Market Concentration Rate
2.9.2 Global 5 and 10 Largest Aquaculture Therapeutics Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Aquaculture Therapeutics Production by Region
3.1 Global Aquaculture Therapeutics Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Aquaculture Therapeutics Production Value by Region (2018-2029)
3.2.1 Global Aquaculture Therapeutics Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Aquaculture Therapeutics by Region (2024-2029)
3.3 Global Aquaculture Therapeutics Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Aquaculture Therapeutics Production by Region (2018-2029)
3.4.1 Global Aquaculture Therapeutics Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Aquaculture Therapeutics by Region (2024-2029)
3.5 Global Aquaculture Therapeutics Market Price Analysis by Region (2018-2023)
3.6 Global Aquaculture Therapeutics Production and Value, Year-over-Year Growth
3.6.1 North America Aquaculture Therapeutics Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Aquaculture Therapeutics Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Aquaculture Therapeutics Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Aquaculture Therapeutics Production Value Estimates and Forecasts (2018-2029)
4 Aquaculture Therapeutics Consumption by Region
4.1 Global Aquaculture Therapeutics Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Aquaculture Therapeutics Consumption by Region (2018-2029)
4.2.1 Global Aquaculture Therapeutics Consumption by Region (2018-2023)
4.2.2 Global Aquaculture Therapeutics Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Aquaculture Therapeutics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Aquaculture Therapeutics Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Aquaculture Therapeutics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Aquaculture Therapeutics Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Aquaculture Therapeutics Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Aquaculture Therapeutics Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Aquaculture Therapeutics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Aquaculture Therapeutics Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Aquaculture Therapeutics Production by Type (2018-2029)
5.1.1 Global Aquaculture Therapeutics Production by Type (2018-2023)
5.1.2 Global Aquaculture Therapeutics Production by Type (2024-2029)
5.1.3 Global Aquaculture Therapeutics Production Market Share by Type (2018-2029)
5.2 Global Aquaculture Therapeutics Production Value by Type (2018-2029)
5.2.1 Global Aquaculture Therapeutics Production Value by Type (2018-2023)
5.2.2 Global Aquaculture Therapeutics Production Value by Type (2024-2029)
5.2.3 Global Aquaculture Therapeutics Production Value Market Share by Type (2018-2029)
5.3 Global Aquaculture Therapeutics Price by Type (2018-2029)
6 Segment by Application
6.1 Global Aquaculture Therapeutics Production by Application (2018-2029)
6.1.1 Global Aquaculture Therapeutics Production by Application (2018-2023)
6.1.2 Global Aquaculture Therapeutics Production by Application (2024-2029)
6.1.3 Global Aquaculture Therapeutics Production Market Share by Application (2018-2029)
6.2 Global Aquaculture Therapeutics Production Value by Application (2018-2029)
6.2.1 Global Aquaculture Therapeutics Production Value by Application (2018-2023)
6.2.2 Global Aquaculture Therapeutics Production Value by Application (2024-2029)
6.2.3 Global Aquaculture Therapeutics Production Value Market Share by Application (2018-2029)
6.3 Global Aquaculture Therapeutics Price by Application (2018-2029)
7 Key Companies Profiled
7.1 TunaTech GmbH
7.1.1 TunaTech GmbH Aquaculture Therapeutics Corporation Information
7.1.2 TunaTech GmbH Aquaculture Therapeutics Product Portfolio
7.1.3 TunaTech GmbH Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.1.4 TunaTech GmbH Main Business and Markets Served
7.1.5 TunaTech GmbH Recent Developments/Updates
7.2 ViAqua Therapeutics Ltd.
7.2.1 ViAqua Therapeutics Ltd. Aquaculture Therapeutics Corporation Information
7.2.2 ViAqua Therapeutics Ltd. Aquaculture Therapeutics Product Portfolio
7.2.3 ViAqua Therapeutics Ltd. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.2.4 ViAqua Therapeutics Ltd. Main Business and Markets Served
7.2.5 ViAqua Therapeutics Ltd. Recent Developments/Updates
7.3 Alpharma Inc.
7.3.1 Alpharma Inc. Aquaculture Therapeutics Corporation Information
7.3.2 Alpharma Inc. Aquaculture Therapeutics Product Portfolio
7.3.3 Alpharma Inc. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Alpharma Inc. Main Business and Markets Served
7.3.5 Alpharma Inc. Recent Developments/Updates
7.4 Blue Ridge Aquaculture
7.4.1 Blue Ridge Aquaculture Aquaculture Therapeutics Corporation Information
7.4.2 Blue Ridge Aquaculture Aquaculture Therapeutics Product Portfolio
7.4.3 Blue Ridge Aquaculture Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Blue Ridge Aquaculture Main Business and Markets Served
7.4.5 Blue Ridge Aquaculture Recent Developments/Updates
7.5 Cermaq ASA
7.5.1 Cermaq ASA Aquaculture Therapeutics Corporation Information
7.5.2 Cermaq ASA Aquaculture Therapeutics Product Portfolio
7.5.3 Cermaq ASA Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Cermaq ASA Main Business and Markets Served
7.5.5 Cermaq ASA Recent Developments/Updates
7.6 Cooke Aquaculture
7.6.1 Cooke Aquaculture Aquaculture Therapeutics Corporation Information
7.6.2 Cooke Aquaculture Aquaculture Therapeutics Product Portfolio
7.6.3 Cooke Aquaculture Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Cooke Aquaculture Main Business and Markets Served
7.6.5 Cooke Aquaculture Recent Developments/Updates
7.7 Nireus Aquaculture S.A.
7.7.1 Nireus Aquaculture S.A. Aquaculture Therapeutics Corporation Information
7.7.2 Nireus Aquaculture S.A. Aquaculture Therapeutics Product Portfolio
7.7.3 Nireus Aquaculture S.A. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Nireus Aquaculture S.A. Main Business and Markets Served
7.7.5 Nireus Aquaculture S.A. Recent Developments/Updates
7.8 Tassal group Ltd.
7.8.1 Tassal group Ltd. Aquaculture Therapeutics Corporation Information
7.8.2 Tassal group Ltd. Aquaculture Therapeutics Product Portfolio
7.8.3 Tassal group Ltd. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Tassal group Ltd. Main Business and Markets Served
7.7.5 Tassal group Ltd. Recent Developments/Updates
7.9 Nireus S.A.
7.9.1 Nireus S.A. Aquaculture Therapeutics Corporation Information
7.9.2 Nireus S.A. Aquaculture Therapeutics Product Portfolio
7.9.3 Nireus S.A. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Nireus S.A. Main Business and Markets Served
7.9.5 Nireus S.A. Recent Developments/Updates
7.10 Unima Group
7.10.1 Unima Group Aquaculture Therapeutics Corporation Information
7.10.2 Unima Group Aquaculture Therapeutics Product Portfolio
7.10.3 Unima Group Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Unima Group Main Business and Markets Served
7.10.5 Unima Group Recent Developments/Updates
7.11 Nutreco Holding N.V.
7.11.1 Nutreco Holding N.V. Aquaculture Therapeutics Corporation Information
7.11.2 Nutreco Holding N.V. Aquaculture Therapeutics Product Portfolio
7.11.3 Nutreco Holding N.V. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Nutreco Holding N.V. Main Business and Markets Served
7.11.5 Nutreco Holding N.V. Recent Developments/Updates
7.12 Kona Bay Marine Resources
7.12.1 Kona Bay Marine Resources Aquaculture Therapeutics Corporation Information
7.12.2 Kona Bay Marine Resources Aquaculture Therapeutics Product Portfolio
7.12.3 Kona Bay Marine Resources Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Kona Bay Marine Resources Main Business and Markets Served
7.12.5 Kona Bay Marine Resources Recent Developments/Updates
7.13 Royal Greenland
7.13.1 Royal Greenland Aquaculture Therapeutics Corporation Information
7.13.2 Royal Greenland Aquaculture Therapeutics Product Portfolio
7.13.3 Royal Greenland Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Royal Greenland Main Business and Markets Served
7.13.5 Royal Greenland Recent Developments/Updates
7.14 Sea Watch International Ltd.
7.14.1 Sea Watch International Ltd. Aquaculture Therapeutics Corporation Information
7.14.2 Sea Watch International Ltd. Aquaculture Therapeutics Product Portfolio
7.14.3 Sea Watch International Ltd. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Sea Watch International Ltd. Main Business and Markets Served
7.14.5 Sea Watch International Ltd. Recent Developments/Updates
7.15 Selonda Aquaculture S.A.
7.15.1 Selonda Aquaculture S.A. Aquaculture Therapeutics Corporation Information
7.15.2 Selonda Aquaculture S.A. Aquaculture Therapeutics Product Portfolio
7.15.3 Selonda Aquaculture S.A. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Selonda Aquaculture S.A. Main Business and Markets Served
7.15.5 Selonda Aquaculture S.A. Recent Developments/Updates
7.16 StarKist Taylor Shellfish Inc.
7.16.1 StarKist Taylor Shellfish Inc. Aquaculture Therapeutics Corporation Information
7.16.2 StarKist Taylor Shellfish Inc. Aquaculture Therapeutics Product Portfolio
7.16.3 StarKist Taylor Shellfish Inc. Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.16.4 StarKist Taylor Shellfish Inc. Main Business and Markets Served
7.16.5 StarKist Taylor Shellfish Inc. Recent Developments/Updates
7.17 TriMarine International
7.17.1 TriMarine International Aquaculture Therapeutics Corporation Information
7.17.2 TriMarine International Aquaculture Therapeutics Product Portfolio
7.17.3 TriMarine International Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.17.4 TriMarine International Main Business and Markets Served
7.17.5 TriMarine International Recent Developments/Updates
7.18 Seafood Company
7.18.1 Seafood Company Aquaculture Therapeutics Corporation Information
7.18.2 Seafood Company Aquaculture Therapeutics Product Portfolio
7.18.3 Seafood Company Aquaculture Therapeutics Production, Value, Price and Gross Margin (2018-2023)
7.18.4 Seafood Company Main Business and Markets Served
7.18.5 Seafood Company Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Aquaculture Therapeutics Industry Chain Analysis
8.2 Aquaculture Therapeutics Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Aquaculture Therapeutics Production Mode & Process
8.4 Aquaculture Therapeutics Sales and Marketing
8.4.1 Aquaculture Therapeutics Sales Channels
8.4.2 Aquaculture Therapeutics Distributors
8.5 Aquaculture Therapeutics Customers
9 Aquaculture Therapeutics Market Dynamics
9.1 Aquaculture Therapeutics Industry Trends
9.2 Aquaculture Therapeutics Market Drivers
9.3 Aquaculture Therapeutics Market Challenges
9.4 Aquaculture Therapeutics Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Aquaculture Therapeutics Market Value by Type, (US$ Million) & (2022 VS 2029)
Table 2. Global Aquaculture Therapeutics Market Value by Application, (US$ Million) & (2022 VS 2029)
Table 3. Global Aquaculture Therapeutics Production Capacity (K Units) by Manufacturers in 2022
Table 4. Global Aquaculture Therapeutics Production by Manufacturers (2018-2023) & (K Units)
Table 5. Global Aquaculture Therapeutics Production Market Share by Manufacturers (2018-2023)
Table 6. Global Aquaculture Therapeutics Production Value by Manufacturers (2018-2023) & (US$ Million)
Table 7. Global Aquaculture Therapeutics Production Value Share by Manufacturers (2018-2023)
Table 8. Global Aquaculture Therapeutics Industry Ranking 2021 VS 2022 VS 2023
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aquaculture Therapeutics as of 2022)
Table 10. Global Market Aquaculture Therapeutics Average Price by Manufacturers (USD/Unit) & (2018-2023)
Table 11. Manufacturers Aquaculture Therapeutics Production Sites and Area Served
Table 12. Manufacturers Aquaculture Therapeutics Product Types
Table 13. Global Aquaculture Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Aquaculture Therapeutics Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Aquaculture Therapeutics Production Value (US$ Million) by Region (2018-2023)
Table 17. Global Aquaculture Therapeutics Production Value Market Share by Region (2018-2023)
Table 18. Global Aquaculture Therapeutics Production Value (US$ Million) Forecast by Region (2024-2029)
Table 19. Global Aquaculture Therapeutics Production Value Market Share Forecast by Region (2024-2029)
Table 20. Global Aquaculture Therapeutics Production Comparison by Region: 2018 VS 2022 VS 2029 (K Units)
Table 21. Global Aquaculture Therapeutics Production (K Units) by Region (2018-2023)
Table 22. Global Aquaculture Therapeutics Production Market Share by Region (2018-2023)
Table 23. Global Aquaculture Therapeutics Production (K Units) Forecast by Region (2024-2029)
Table 24. Global Aquaculture Therapeutics Production Market Share Forecast by Region (2024-2029)
Table 25. Global Aquaculture Therapeutics Market Average Price (USD/Unit) by Region (2018-2023)
Table 26. Global Aquaculture Therapeutics Market Average Price (USD/Unit) by Region (2024-2029)
Table 27. Global Aquaculture Therapeutics Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (K Units)
Table 28. Global Aquaculture Therapeutics Consumption by Region (2018-2023) & (K Units)
Table 29. Global Aquaculture Therapeutics Consumption Market Share by Region (2018-2023)
Table 30. Global Aquaculture Therapeutics Forecasted Consumption by Region (2024-2029) & (K Units)
Table 31. Global Aquaculture Therapeutics Forecasted Consumption Market Share by Region (2018-2023)
Table 32. North America Aquaculture Therapeutics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (K Units)
Table 33. North America Aquaculture Therapeutics Consumption by Country (2018-2023) & (K Units)
Table 34. North America Aquaculture Therapeutics Consumption by Country (2024-2029) & (K Units)
Table 35. Europe Aquaculture Therapeutics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (K Units)
Table 36. Europe Aquaculture Therapeutics Consumption by Country (2018-2023) & (K Units)
Table 37. Europe Aquaculture Therapeutics Consumption by Country (2024-2029) & (K Units)
Table 38. Asia Pacific Aquaculture Therapeutics Consumption Growth Rate by Region: 2018 VS 2022 VS 2029 (K Units)
Table 39. Asia Pacific Aquaculture Therapeutics Consumption by Region (2018-2023) & (K Units)
Table 40. Asia Pacific Aquaculture Therapeutics Consumption by Region (2024-2029) & (K Units)
Table 41. Latin America, Middle East & Africa Aquaculture Therapeutics Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (K Units)
Table 42. Latin America, Middle East & Africa Aquaculture Therapeutics Consumption by Country (2018-2023) & (K Units)
Table 43. Latin America, Middle East & Africa Aquaculture Therapeutics Consumption by Country (2024-2029) & (K Units)
Table 44. Global Aquaculture Therapeutics Production (K Units) by Type (2018-2023)
Table 45. Global Aquaculture Therapeutics Production (K Units) by Type (2024-2029)
Table 46. Global Aquaculture Therapeutics Production Market Share by Type (2018-2023)
Table 47. Global Aquaculture Therapeutics Production Market Share by Type (2024-2029)
Table 48. Global Aquaculture Therapeutics Production Value (US$ Million) by Type (2018-2023)
Table 49. Global Aquaculture Therapeutics Production Value (US$ Million) by Type (2024-2029)
Table 50. Global Aquaculture Therapeutics Production Value Share by Type (2018-2023)
Table 51. Global Aquaculture Therapeutics Production Value Share by Type (2024-2029)
Table 52. Global Aquaculture Therapeutics Price (USD/Unit) by Type (2018-2023)
Table 53. Global Aquaculture Therapeutics Price (USD/Unit) by Type (2024-2029)
Table 54. Global Aquaculture Therapeutics Production (K Units) by Application (2018-2023)
Table 55. Global Aquaculture Therapeutics Production (K Units) by Application (2024-2029)
Table 56. Global Aquaculture Therapeutics Production Market Share by Application (2018-2023)
Table 57. Global Aquaculture Therapeutics Production Market Share by Application (2024-2029)
Table 58. Global Aquaculture Therapeutics Production Value (US$ Million) by Application (2018-2023)
Table 59. Global Aquaculture Therapeutics Production Value (US$ Million) by Application (2024-2029)
Table 60. Global Aquaculture Therapeutics Production Value Share by Application (2018-2023)
Table 61. Global Aquaculture Therapeutics Production Value Share by Application (2024-2029)
Table 62. Global Aquaculture Therapeutics Price (USD/Unit) by Application (2018-2023)
Table 63. Global Aquaculture Therapeutics Price (USD/Unit) by Application (2024-2029)
Table 64. TunaTech GmbH Aquaculture Therapeutics Corporation Information
Table 65. TunaTech GmbH Specification and Application
Table 66. TunaTech GmbH Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. TunaTech GmbH Main Business and Markets Served
Table 68. TunaTech GmbH Recent Developments/Updates
Table 69. ViAqua Therapeutics Ltd. Aquaculture Therapeutics Corporation Information
Table 70. ViAqua Therapeutics Ltd. Specification and Application
Table 71. ViAqua Therapeutics Ltd. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. ViAqua Therapeutics Ltd. Main Business and Markets Served
Table 73. ViAqua Therapeutics Ltd. Recent Developments/Updates
Table 74. Alpharma Inc. Aquaculture Therapeutics Corporation Information
Table 75. Alpharma Inc. Specification and Application
Table 76. Alpharma Inc. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Alpharma Inc. Main Business and Markets Served
Table 78. Alpharma Inc. Recent Developments/Updates
Table 79. Blue Ridge Aquaculture Aquaculture Therapeutics Corporation Information
Table 80. Blue Ridge Aquaculture Specification and Application
Table 81. Blue Ridge Aquaculture Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Blue Ridge Aquaculture Main Business and Markets Served
Table 83. Blue Ridge Aquaculture Recent Developments/Updates
Table 84. Cermaq ASA Aquaculture Therapeutics Corporation Information
Table 85. Cermaq ASA Specification and Application
Table 86. Cermaq ASA Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Cermaq ASA Main Business and Markets Served
Table 88. Cermaq ASA Recent Developments/Updates
Table 89. Cooke Aquaculture Aquaculture Therapeutics Corporation Information
Table 90. Cooke Aquaculture Specification and Application
Table 91. Cooke Aquaculture Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Cooke Aquaculture Main Business and Markets Served
Table 93. Cooke Aquaculture Recent Developments/Updates
Table 94. Nireus Aquaculture S.A. Aquaculture Therapeutics Corporation Information
Table 95. Nireus Aquaculture S.A. Specification and Application
Table 96. Nireus Aquaculture S.A. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Nireus Aquaculture S.A. Main Business and Markets Served
Table 98. Nireus Aquaculture S.A. Recent Developments/Updates
Table 99. Tassal group Ltd. Aquaculture Therapeutics Corporation Information
Table 100. Tassal group Ltd. Specification and Application
Table 101. Tassal group Ltd. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Tassal group Ltd. Main Business and Markets Served
Table 103. Tassal group Ltd. Recent Developments/Updates
Table 104. Nireus S.A. Aquaculture Therapeutics Corporation Information
Table 105. Nireus S.A. Specification and Application
Table 106. Nireus S.A. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Nireus S.A. Main Business and Markets Served
Table 108. Nireus S.A. Recent Developments/Updates
Table 109. Unima Group Aquaculture Therapeutics Corporation Information
Table 110. Unima Group Specification and Application
Table 111. Unima Group Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Unima Group Main Business and Markets Served
Table 113. Unima Group Recent Developments/Updates
Table 114. Nutreco Holding N.V. Aquaculture Therapeutics Corporation Information
Table 115. Nutreco Holding N.V. Specification and Application
Table 116. Nutreco Holding N.V. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Nutreco Holding N.V. Main Business and Markets Served
Table 118. Nutreco Holding N.V. Recent Developments/Updates
Table 119. Kona Bay Marine Resources Aquaculture Therapeutics Corporation Information
Table 120. Kona Bay Marine Resources Specification and Application
Table 121. Kona Bay Marine Resources Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Kona Bay Marine Resources Main Business and Markets Served
Table 123. Kona Bay Marine Resources Recent Developments/Updates
Table 124. Royal Greenland Aquaculture Therapeutics Corporation Information
Table 125. Royal Greenland Specification and Application
Table 126. Royal Greenland Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Royal Greenland Main Business and Markets Served
Table 128. Royal Greenland Recent Developments/Updates
Table 129. Sea Watch International Ltd. Aquaculture Therapeutics Corporation Information
Table 130. Sea Watch International Ltd. Specification and Application
Table 131. Sea Watch International Ltd. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Sea Watch International Ltd. Main Business and Markets Served
Table 133. Sea Watch International Ltd. Recent Developments/Updates
Table 134. Sea Watch International Ltd. Aquaculture Therapeutics Corporation Information
Table 135. Selonda Aquaculture S.A. Specification and Application
Table 136. Selonda Aquaculture S.A. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Selonda Aquaculture S.A. Main Business and Markets Served
Table 138. Selonda Aquaculture S.A. Recent Developments/Updates
Table 139. StarKist Taylor Shellfish Inc. Aquaculture Therapeutics Corporation Information
Table 140. StarKist Taylor Shellfish Inc. Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. StarKist Taylor Shellfish Inc. Main Business and Markets Served
Table 142. StarKist Taylor Shellfish Inc. Recent Developments/Updates
Table 143. TriMarine International Aquaculture Therapeutics Corporation Information
Table 144. TriMarine International Specification and Application
Table 145. TriMarine International Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. TriMarine International Main Business and Markets Served
Table 147. TriMarine International Recent Developments/Updates
Table 148. Seafood Company Aquaculture Therapeutics Corporation Information
Table 149. Seafood Company Specification and Application
Table 150. Seafood Company Aquaculture Therapeutics Production (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. Seafood Company Main Business and Markets Served
Table 152. Seafood Company Recent Developments/Updates
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Aquaculture Therapeutics Distributors List
Table 156. Aquaculture Therapeutics Customers List
Table 157. Aquaculture Therapeutics Market Trends
Table 158. Aquaculture Therapeutics Market Drivers
Table 159. Aquaculture Therapeutics Market Challenges
Table 160. Aquaculture Therapeutics Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aquaculture Therapeutics
Figure 2. Global Aquaculture Therapeutics Market Value by Type, (US$ Million) & (2022 VS 2029)
Figure 3. Global Aquaculture Therapeutics Market Share by Type: 2022 VS 2029
Figure 4. Formalin Solution Product Picture
Figure 5. Chorionic Gonadotropin Product Picture
Figure 6. Florfenicol Product Picture
Figure 7. Tricaine Methane Sulfonate Product Picture
Figure 8. Oxytetracycline Product Picture
Figure 9. Hydrogen Peroxide Product Picture
Figure 10. Global Aquaculture Therapeutics Market Value by Application, (US$ Million) & (2022 VS 2029)
Figure 11. Global Aquaculture Therapeutics Market Share by Application: 2022 VS 2029
Figure 12. Veterinary Pharmacies
Figure 13. Veterinary Hospitals
Figure 14. E-Commerce
Figure 15. Veterinary Clinics
Figure 16. Global Aquaculture Therapeutics Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Aquaculture Therapeutics Production Value (US$ Million) & (2018-2029)
Figure 18. Global Aquaculture Therapeutics Production Capacity (K Units) & (2018-2029)
Figure 19. Global Aquaculture Therapeutics Production (K Units) & (2018-2029)
Figure 20. Global Aquaculture Therapeutics Average Price (USD/Unit) & (2018-2029)
Figure 21. Aquaculture Therapeutics Report Years Considered
Figure 22. Aquaculture Therapeutics Production Share by Manufacturers in 2022
Figure 23. Aquaculture Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. The Global 5 and 10 Largest Players: Market Share by Aquaculture Therapeutics Revenue in 2022
Figure 25. Global Aquaculture Therapeutics Production Value by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 26. Global Aquaculture Therapeutics Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 27. Global Aquaculture Therapeutics Production Comparison by Region: 2018 VS 2022 VS 2029 (K Units)
Figure 28. Global Aquaculture Therapeutics Production Market Share by Region: 2018 VS 2022 VS 2029
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs